PHARMACOLOGICAL ACTIVITY OF A LOW-MOLECULAR-WEIGHT DERMATAN SULFATE (DESMIN) IN HEALTHY-VOLUNTEERS

被引：19
|
作者：
DETTORI, AG [1 ]
GALLI, G [1 ]
MANOTTI, C [1 ]
PALAZZINI, E [1 ]
机构：
[1] DIREZ MED ALFA WASSERMANN, BOLOGNA, ITALY
来源：
SEMINARS IN THROMBOSIS AND HEMOSTASIS | 1994年 / 20卷 / 03期
关键词：
D O I：
10.1055/s-2007-1001911
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：259 / 265
页数：7
相关论文
共 50 条
  • [21] LOW-MOLECULAR-WEIGHT DERMATAN SULFATE AS AN ANTITHROMBOTIC AGENT - STRUCTURE-ACTIVITY RELATIONSHIP STUDIES
    LINHARDT, RJ
    DESAI, UR
    LIU, J
    PERVIN, A
    HOPPENSTEADT, D
    FAREED, J
    BIOCHEMICAL PHARMACOLOGY, 1994, 47 (07) : 1241 - 1252
  • [22] Thrombolysis enhancing activity of a low molecular weight dermatan sulfate (Desmin 370) in experimental pulmonary embolism in rats
    Colucci, M
    Sardella, L
    Barbanti, M
    Calanni, F
    Semeraro, N
    THROMBOSIS RESEARCH, 1997, 87 (05) : 441 - 446
  • [23] THE ADDITIVE EFFECT OF LOW-MOLECULAR-WEIGHT HEPARINS ON THROMBIN INHIBITION BY DERMATAN SULFATE
    COSMI, B
    AGNELLI, G
    YOUNG, E
    HIRSH, J
    WEITZ, J
    THROMBOSIS AND HAEMOSTASIS, 1993, 70 (03) : 443 - 447
  • [24] CLINICAL-EVALUATION OF PAIN DURING SUBCUTANEOUS INJECTIONS OF LOW-MOLECULAR-WEIGHT HEPARINS IN HEALTHY-VOLUNTEERS
    BILLON, N
    GLOAGUEN, F
    FUNCKBRENTANO, C
    JAILLON, P
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 37 (04) : 395 - 397
  • [25] ANTITHROMBOTIC ACTIVITY OF DESMIN-370 - COMPARISON WITH A HIGH-MOLECULAR-WEIGHT DERMATAN SULFATE
    BARBANTI, M
    CALANNI, F
    BABBINI, M
    BERGONZINI, G
    PARMA, B
    MARCHI, E
    THROMBOSIS RESEARCH, 1993, 71 (05) : 417 - 422
  • [26] THERAPEUTIC EFFECT OF A LOW-MOLECULAR-WEIGHT DERMATAN SULFATE (DESMIN 370) IN RAT VENOUS THROMBOSIS - EVIDENCE FOR AN ANTICOAGULANT-INDEPENDENT MECHANISM
    BARBANTI, M
    CALANNI, F
    MILANI, MR
    MARCHI, E
    SEMERARO, N
    COLUCCI, M
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (02) : 147 - 151
  • [27] EFFECT OF SUBCUTANEOUSLY ADMINISTERED DERMATAN SULFATE ON THE COAGULATION AND FIBRINOLYTIC PARAMETERS OF HEALTHY-VOLUNTEERS
    TRIPODI, A
    MOIA, M
    BOTTASSO, B
    TENCONI, PM
    GIANESE, F
    MANNUCCI, PM
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1303 - 1303
  • [28] PHARMACOKINETICS AND PHARMACODYNAMICS OF DERMATAN SULFATE AFTER INTRAVENOUS AND INTRAMUSCULAR ADMINISTRATION TO HEALTHY-VOLUNTEERS
    BLARDI, P
    MESSA, GL
    URSO, R
    DIPERRI, T
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1993, 13 (04) : 231 - 238
  • [29] Pharmacology of a new low molecular weight dermatan sulphate (Desmin) in healthy volunteers: Repeated daily intramuscular administration of 400 mg for a week
    Dettori, AG
    Zamboni, V
    Manotti, C
    Canova, N
    Barbanti, M
    Palazzini, E
    THROMBOSIS RESEARCH, 1996, 83 (01) : 103 - 109
  • [30] PROPHYLACTIC DOSES OF A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARINE) - CHRONOPHARMACOLOGICAL STUDY AFTER SUBCUTANEOUS ADMINISTRATION TO HEALTHY-VOLUNTEERS
    MISMETTI, P
    PERPOINT, B
    LAPORTESIMITSIDIS, S
    TARDYPONCET, B
    REYNAUD, J
    CHERRAH, Y
    OLLAGNIER, M
    QUENEAU, P
    DECOUSUS, H
    THERAPIE, 1992, 47 (06): : 557 - 560
12345